{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T14:17:36Z","timestamp":1791037056136,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,10,11]],"date-time":"2011-10-11T00:00:00Z","timestamp":1318291200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genet"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Germline mutations in either of the two tumor-suppressor genes, <jats:italic>BRCA1<\/jats:italic> and <jats:italic>BRCA2<\/jats:italic>, account for a significant proportion of hereditary breast and ovarian cancer cases. Most of these mutations consist of deletions, insertions, nonsense mutations, and splice variants, however an increasing number of large genomic rearrangements have been identified in these genes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We analysed <jats:italic>BRCA1<\/jats:italic> and <jats:italic>BRCA2<\/jats:italic> genes by direct sequencing and MLPA. We confirmed the results by an alternative MLPA kit and characterized the <jats:italic>BRCA1<\/jats:italic> deletion by Array CGH.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>We describe the first case of a patient with no strong family history of the disease who developed early-onset bilateral breast cancer with a <jats:italic>de novo<\/jats:italic> complete <jats:italic>BRCA1<\/jats:italic> gene deletion in the germinal line. The detected deletion started from the region surrounding the <jats:italic>VAT1<\/jats:italic>\n              <jats:italic>locus<\/jats:italic> to the beginning of <jats:italic>NBR1<\/jats:italic> gene, including the <jats:italic>RND2<\/jats:italic>, \u03a8<jats:italic>BRCA1<\/jats:italic>, <jats:italic>BRCA1<\/jats:italic> and <jats:italic>NBR2<\/jats:italic> complete genes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>This finding supports the large genomic rearrangement screening of <jats:italic>BRCA<\/jats:italic> genes in young breast cancer patients without family history, as well as in hereditary breast and ovarian cancer families previously tested negative for other variations.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2350-12-134","type":"journal-article","created":{"date-parts":[[2011,11,3]],"date-time":"2011-11-03T19:24:33Z","timestamp":1320348273000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["A de novo complete BRCA1 gene deletion identified in a Spanish woman with early bilateral breast cancer"],"prefix":"10.1186","volume":"12","author":[{"given":"Zaida","family":"Garcia-Casado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Fernandez-Serra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Rubio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Llopis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Llombart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose A","family":"Lopez-Guerrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,10,11]]},"reference":[{"key":"868_CR1","unstructured":"Cancer Facts & Figures 2010. Atlanta, Ga: American Cancer Society."},{"issue":"5182","key":"868_CR2","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1126\/science.7545954","volume":"266","author":"Y Miki","year":"1994","unstructured":"Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, et al: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science New York, NY. 1994, 266 (5182): 66-71. 10.1126\/science.7545954.","journal-title":"Science New York, NY"},{"issue":"6559","key":"868_CR3","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/378789a0","volume":"378","author":"R Wooster","year":"1995","unstructured":"Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C, Micklem G: Identification of the breast cancer susceptibility gene BRCA2. Nature. 1995, 378 (6559): 789-792. 10.1038\/378789a0.","journal-title":"Nature"},{"key":"868_CR4","first-page":"508","volume-title":"Prevalence of BRCA1 mutations in triple negative breast cancer (BC)","author":"MJ Kandel","year":"2006","unstructured":"Kandel MJ, Stadler Z, Masciari S, Collins L, Schnitt S, Harris L, Miron A, Richardson A, Garber JE: Prevalence of BRCA1 mutations in triple negative breast cancer (BC). 2006, 24: 508-"},{"key":"868_CR5","first-page":"1588","volume":"58","author":"F Eisinger","year":"1998","unstructured":"Eisinger F, Jacquemier J, Charpin C, Stoppa-Lyonnet D, Paillerets BB, Peyrat JP, Longy M, Guinebreti\u00e8re JM, Sauvan R, Noguchi T: Mutations at BRCA1: the medullary breast carcinoma revisited. AACR. 1998, 58: 1588-","journal-title":"AACR"},{"key":"868_CR6","first-page":"R728","volume":"7","author":"P Pohlreich","year":"2005","unstructured":"Pohlreich P, Zikan M, Stribrna J, Kleibl Z, Janatova M, Kotlas J, Zidovska J, Novotny J, Petruzelka L, Szabo C: High proportion of recurrent germline mutations in the BRCA1 gene in breast and ovarian cancer patients from the Prague area. BioMed Central Ltd. 2005, 7: R728-R736.","journal-title":"BioMed Central Ltd"},{"key":"868_CR7","first-page":"81","volume":"85","author":"PTC Iau","year":"2004","unstructured":"Iau PTC, Marafie M, Ali A, Sng JH, Macmillan RD, Pinder S, Denley HE, Ellis IO, Wenzyck P, Scott N: Are medullary breast cancers an indication for BRCA1 mutation screening?. A mutation analysis of 42 cases of medullary breast cancer Springer. 2004, 85: 81-88.","journal-title":"A mutation analysis of 42 cases of medullary breast cancer Springer"},{"key":"868_CR8","first-page":"1482","volume-title":"Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer","author":"WD Foulkes","year":"2003","unstructured":"Foulkes WD, Stefansson IM, Chappuis PO, B\u00e9gin LR, Goffin JR, Wong N, Trudel M, Akslen LA: Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. 2003, Oxford University Press, 95: 1482-"},{"issue":"2","key":"868_CR9","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s10549-010-0817-z","volume":"125","author":"MD Sluiter","year":"2011","unstructured":"Sluiter MD, van Rensburg EJ: Large genomic rearrangements of the BRCA1 and BRCA2 genes: review of the literature and report of a novel BRCA1 mutation. Breast cancer research and treatment. 2011, 125 (2): 325-49. 10.1007\/s10549-010-0817-z.","journal-title":"Breast cancer research and treatment"},{"issue":"1","key":"868_CR10","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s10549-008-9978-4","volume":"114","author":"A Peixoto","year":"2009","unstructured":"Peixoto A, Santos C, Rocha P, Pinheiro M, Principe S, Pereira D, Rodrigues H, Castro F, Abreu J, Gusmao L, et al: The c.156_157insAlu BRCA2 rearrangement accounts for more than one-fourth of deleterious BRCA mutations in northern\/central Portugal. Breast cancer research and treatment. 2009, 114 (1): 31-38. 10.1007\/s10549-008-9978-4.","journal-title":"Breast cancer research and treatment"},{"key":"868_CR11","first-page":"562","volume-title":"Genetic\/familial high-risk assessment: breast and ovarian","author":"MB Daly","year":"2010","unstructured":"Daly MB, Axilbund JE, Buys S, Crawford B, Farrell CD, Friedman S, Garber JE, Goorha S, Gruber SB, Hampel H: Genetic\/familial high-risk assessment: breast and ovarian. 2010, Harborside Press, LLC, 8: 562-"},{"key":"868_CR12","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1200\/JCO.2008.20.7019","volume":"28","author":"T Byrski","year":"2010","unstructured":"Byrski T, Gronwald J, Huzarski T, Grzybowska E, Budryk M, Stawicka M, Mierzwa T, Szwiec M, Wi niowski R, Siolek M: Pathologic complete response rates in young women with BRCA1-positive breast cancers after neoadjuvant chemotherapy. American Society of Clinical Oncology. 2010, 28: 375-10.1200\/JCO.2008.20.7019.","journal-title":"American Society of Clinical Oncology"},{"key":"868_CR13","first-page":"4702","volume":"16","author":"CK Anders","year":"2010","unstructured":"Anders CK, Winer EP, Ford JM, Dent R, Silver DP, Sledge GW, Carey LA: Poly (ADP-Ribose) Polymerase Inhibition:\"Targeted\" Therapy for Triple-Negative Breast Cancer. AACR. 2010, 16: 4702-","journal-title":"AACR"},{"key":"868_CR14","volume-title":"Mass Med Soc","author":"PC Fong","year":"2009","unstructured":"Fong PC, Boss DS, Yap TA, Tutt A, Wu P, Mergui-Roelvink M, Mortimer P, Swaisland H, Lau A, O'Connor MJ: Inhibition of poly (ADP-ribose) polymerase in tumors from BRCA mutation carriers. Mass Med Soc. 2009"},{"key":"868_CR15","first-page":"193","volume":"8","author":"T Helleday","year":"2008","unstructured":"Helleday T, Petermann E, Lundin C, Hodgson B, Sharma RA: DNA repair pathways as targets for cancer therapy. Nature Publishing Group. 2008, 8: 193-204.","journal-title":"Nature Publishing Group"},{"key":"868_CR16","volume-title":"Elsevier","author":"A Tutt","year":"2010","unstructured":"Tutt A, Robson M, Garber JE, Domchek SM, Audeh MW, Weitzel JN, Friedlander M, Arun B, Loman N, Schmutzler RK: Oral poly (ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial. Elsevier. 2010"},{"issue":"4","key":"868_CR17","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.eururo.2006.04.010","volume":"50","author":"M Burger","year":"2006","unstructured":"Burger M, Burger SJ, Denzinger S, Wild PJ, Wieland WF, Blaszyk H, Obermann EC, Stoehr R, Hartmann A: Elevated microsatellite instability at selected tetranucleotide repeats does not correlate with clinicopathologic features of bladder cancer. European urology. 2006, 50 (4): 770-775. 10.1016\/j.eururo.2006.04.010. discussion 776","journal-title":"European urology"},{"issue":"9","key":"868_CR18","doi-asserted-by":"publisher","first-page":"e67.","DOI":"10.1093\/nar\/gkp215","volume":"37","author":"FO Desmet","year":"2009","unstructured":"Desmet FO, Hamroun D, Lalande M, Collod-Beroud G, Claustres M, Beroud C: Human Splicing Finder: an online bioinformatics tool to predict splicing signals. Nucleic acids research. 2009, 37 (9): e67.-","journal-title":"Nucleic acids research"},{"issue":"8","key":"868_CR19","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1373\/clinchem.2006.070110","volume":"52","author":"M de la Hoya","year":"2006","unstructured":"de la Hoya M, Gutierrez-Enriquez S, Velasco E, Osorio A, Sanchez de Abajo A, Vega A, Salazar R, Esteban E, Llort G, Gonzalez-Sarmiento R, et al: Genomic rearrangements at the BRCA1 locus in Spanish families with breast\/ovarian cancer. Clinical chemistry. 2006, 52 (8): 1480-1485. 10.1373\/clinchem.2006.070110.","journal-title":"Clinical chemistry"},{"issue":"3","key":"868_CR20","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s10549-007-9670-0","volume":"109","author":"M Konecny","year":"2008","unstructured":"Konecny M, Zavodna K, Vranova V, Vizvaryova M, Weismanova E, Mlkva I, Kuglik P, Kausitz J, Bartosova Z: Identification of rare complete BRCA1 gene deletion using a combination of SNP haplotype analysis, MLPA and array-CGH techniques. Breast cancer research and treatment. 2008, 109 (3): 581-583. 10.1007\/s10549-007-9670-0.","journal-title":"Breast cancer research and treatment"},{"issue":"4","key":"868_CR21","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/hmg\/3.4.589","volume":"3","author":"IG Campbell","year":"1994","unstructured":"Campbell IG, Nicolai HM, Foulkes WD, Senger G, Stamp GW, Allan G, Boyer C, Jones K, Bast RC, Solomon E: A novel gene encoding a B-box protein within the BRCA1 region at 17q21.1. Human molecular genetics. 1994, 3 (4): 589-594. 10.1093\/hmg\/3.4.589.","journal-title":"Human molecular genetics"},{"issue":"5728","key":"868_CR22","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1126\/science.1110463","volume":"308","author":"S Lange","year":"2005","unstructured":"Lange S, Xiang F, Yakovenko A, Vihola A, Hackman P, Rostkova E, Kristensen J, Brandmeier B, Franzen G, Hedberg B, et al: The kinase domain of titin controls muscle gene expression and protein turnover. Science (New York, NY. 2005, 308 (5728): 1599-1603. 10.1126\/science.1110463.","journal-title":"Science (New York, NY"},{"issue":"7","key":"868_CR23","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1093\/hmg\/6.7.1057","volume":"6","author":"CF Xu","year":"1997","unstructured":"Xu CF, Brown MA, Nicolai H, Chambers JA, Griffiths BL, Solomon E: Isolation and characterisation of the NBR2 gene which lies head to head with the human BRCA1 gene. Human molecular genetics. 1997, 6 (7): 1057-1062. 10.1093\/hmg\/6.7.1057.","journal-title":"Human molecular genetics"},{"issue":"7209","key":"868_CR24","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/nature07198","volume":"455","author":"JI Heng","year":"2008","unstructured":"Heng JI, Nguyen L, Castro DS, Zimmer C, Wildner H, Armant O, Skowronska-Krawczyk D, Bedogni F, Matter JM, Hevner R, et al: Neurogenin 2 controls cortical neuron migration through regulation of Rnd2. Nature. 2008, 455 (7209): 114-118. 10.1038\/nature07198.","journal-title":"Nature"},{"issue":"11","key":"868_CR25","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1101\/gr.6.11.1029","volume":"6","author":"TM Smith","year":"1996","unstructured":"Smith TM, Lee MK, Szabo CI, Jerome N, McEuen M, Taylor M, Hood L, King MC: Complete genomic sequence and analysis of 117 kb of human DNA containing the gene BRCA1. Genome research. 1996, 6 (11): 1029-1049. 10.1101\/gr.6.11.1029.","journal-title":"Genome research"},{"issue":"4","key":"868_CR26","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/S1097-2765(00)80202-6","volume":"4","author":"ME Moynahan","year":"1999","unstructured":"Moynahan ME, Chiu JW, Koller BH, Jasin M: Brca1 controls homology-directed DNA repair. Molecular cell. 1999, 4 (4): 511-518. 10.1016\/S1097-2765(00)80202-6.","journal-title":"Molecular cell"},{"issue":"2","key":"868_CR27","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1006\/geno.1996.0618","volume":"38","author":"DF Barker","year":"1996","unstructured":"Barker DF, Liu X, Almeida ER: The BRCA1 and 1A1.3B promoters are parallel elements of a genomic duplication at 17q21. Genomics. 1996, 38 (2): 215-222. 10.1006\/geno.1996.0618.","journal-title":"Genomics"},{"issue":"10","key":"868_CR28","doi-asserted-by":"publisher","first-page":"4362","DOI":"10.1073\/pnas.92.10.4362","volume":"92","author":"MA Brown","year":"1995","unstructured":"Brown MA, Jones KA, Nicolai H, Bonjardim M, Black D, McFarlane R, de Jong P, Quirk JP, Lehrach H, Solomon E: Physical mapping, cloning, and identification of genes within a 500-kb region containing BRCA1. Proceedings of the National Academy of Sciences of the United States of America. 1995, 92 (10): 4362-4366. 10.1073\/pnas.92.10.4362.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"4","key":"868_CR29","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1086\/339434","volume":"70","author":"N Puget","year":"2002","unstructured":"Puget N, Gad S, Perrin-Vidoz L, Sinilnikova OM, Stoppa-Lyonnet D, Lenoir GM, Mazoyer S: Distinct BRCA1 rearrangements involving the BRCA1 pseudogene suggest the existence of a recombination hot spot. American journal of human genetics. 2002, 70 (4): 858-865. 10.1086\/339434.","journal-title":"American journal of human genetics"},{"issue":"1","key":"868_CR30","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/1098-2264(2000)9999:9999<::AID-GCC1008>3.0.CO;2-F","volume":"29","author":"SR Payne","year":"2000","unstructured":"Payne SR, Newman B, King MC: Complex germline rearrangement of BRCA1 associated with breast and ovarian cancer. Genes, chromosomes & cancer. 2000, 29 (1): 58-62. 10.1002\/1098-2264(2000)9999:9999<::AID-GCC1008>3.0.CO;2-F.","journal-title":"Genes, chromosomes & cancer"},{"issue":"7","key":"868_CR31","first-page":"1449","volume":"63","author":"FB Hogervorst","year":"2003","unstructured":"Hogervorst FB, Nederlof PM, Gille JJ, McElgunn CJ, Grippeling M, Pruntel R, Regnerus R, van Welsem T, van Spaendonk R, Menko FH, et al: Large genomic deletions and duplications in the BRCA1 gene identified by a novel quantitative method. Cancer research. 2003, 63 (7): 1449-1453.","journal-title":"Cancer research"},{"issue":"2","key":"868_CR32","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1089\/gte.2006.10.104","volume":"10","author":"AM Moisan","year":"2006","unstructured":"Moisan AM, Fortin J, Dumont M, Samson C, Bessette P, Chiquette J, Laframboise R, Lepine J, Lesperance B, Pichette R, et al: No Evidence of BRCA1\/2 genomic rearrangements in high-risk French-Canadian breast\/ovarian cancer families. Genetic testing. 2006, 10 (2): 104-115. 10.1089\/gte.2006.10.104.","journal-title":"Genetic testing"},{"issue":"8","key":"868_CR33","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1007\/s00432-005-0678-8","volume":"131","author":"A Pietschmann","year":"2005","unstructured":"Pietschmann A, Mehdipour P, Mehdipour P, Atri M, Hofmann W, Hosseini-Asl SS, Scherneck S, Mundlos S, Peters H: Mutation analysis of BRCA1 and BRCA2 genes in Iranian high risk breast cancer families. Journal of cancer research and clinical oncology. 2005, 131 (8): 552-558. 10.1007\/s00432-005-0678-8.","journal-title":"Journal of cancer research and clinical oncology"},{"issue":"8","key":"868_CR34","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1158\/1055-9965.EPI-07-0198","volume":"16","author":"JN Weitzel","year":"2007","unstructured":"Weitzel JN, Lagos VI, Herzog JS, Judkins T, Hendrickson B, Ho JS, Ricker CN, Lowstuter KJ, Blazer KR, Tomlinson G, et al: Evidence for common ancestral origin of a recurring BRCA1 genomic rearrangement identified in high-risk Hispanic families. Cancer Epidemiol Biomarkers Prev. 2007, 16 (8): 1615-1620. 10.1158\/1055-9965.EPI-07-0198.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"868_CR35","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.cancergencyto.2005.07.005","volume":"168","author":"S Preisler-Adams","year":"2006","unstructured":"Preisler-Adams S, Schonbuchner I, Fiebig B, Welling B, Dworniczak B, Weber BH: Gross rearrangements in BRCA1 but not BRCA2 play a notable role in predisposition to breast and ovarian cancer in high-risk families of German origin. Cancer genetics and cytogenetics. 2006, 168 (1): 44-49. 10.1016\/j.cancergencyto.2005.07.005.","journal-title":"Cancer genetics and cytogenetics"},{"issue":"6","key":"868_CR36","doi-asserted-by":"publisher","first-page":"654.","DOI":"10.1002\/humu.9148","volume":"21","author":"S Gad","year":"2003","unstructured":"Gad S, Bieche I, Barrois M, Casilli F, Pages-Berhouet S, Dehainault C, Gauthier-Villars M, Bensimon A, Aurias A, Lidereau R, et al: Characterisation of a 161 kb deletion extending from the NBR1 to the BRCA1 genes in a French breast-ovarian cancer family. Human mutation. 2003, 21 (6): 654.-","journal-title":"Human mutation"},{"issue":"1","key":"868_CR37","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10549-009-0494-y","volume":"121","author":"O Diez","year":"2010","unstructured":"Diez O, Gutierrez-Enriquez S, Mediano C, Masas M, Saura C, Gadea N, Balmana J: A novel de novo BRCA2 mutation of paternal origin identified in a Spanish woman with early onset bilateral breast cancer. Breast cancer research and treatment. 2010, 121 (1): 221-225. 10.1007\/s10549-009-0494-y.","journal-title":"Breast cancer research and treatment"},{"issue":"2","key":"868_CR38","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1086\/302503","volume":"65","author":"A Tesoriero","year":"1999","unstructured":"Tesoriero A, Andersen C, Southey M, Somers G, McKay M, Armes J, McCredie M, Giles G, Hopper JL, Venter D: De novo BRCA1 mutation in a patient with breast cancer and an inherited BRCA2 mutation. American journal of human genetics. 1999, 65 (2): 567-569. 10.1086\/302503.","journal-title":"American journal of human genetics"},{"issue":"2","key":"868_CR39","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1136\/jmg.39.2.126","volume":"39","author":"M Robson","year":"2002","unstructured":"Robson M, Scheuer L, Nafa K, Ellis N, Offit K: Unique de novo mutation of BRCA2 in a woman with early onset breast cancer. Journal of medical genetics. 2002, 39 (2): 126-128. 10.1136\/jmg.39.2.126.","journal-title":"Journal of medical genetics"},{"issue":"2","key":"868_CR40","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1136\/jmg.38.2.102","volume":"38","author":"RB van der Luijt","year":"2001","unstructured":"van der Luijt RB, van Zon PH, Jansen RP, van der Sijs-Bos CJ, Warlam-Rodenhuis CC, Ausems MG: De novo recurrent germline mutation of the BRCA2 gene in a patient with early onset breast cancer. Journal of medical genetics. 2001, 38 (2): 102-105. 10.1136\/jmg.38.2.102.","journal-title":"Journal of medical genetics"},{"issue":"5","key":"868_CR41","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/j.1399-0004.2009.01246.x","volume":"76","author":"M Marshall","year":"2009","unstructured":"Marshall M, Solomon S, Lawrence Wickerham D: Case report: de novo BRCA2 gene mutation in a 35-year-old woman with breast cancer. Clinical genetics. 2009, 76 (5): 427-430. 10.1111\/j.1399-0004.2009.01246.x.","journal-title":"Clinical genetics"},{"issue":"4","key":"868_CR42","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s10689-009-9270-8","volume":"8","author":"E Edwards","year":"2009","unstructured":"Edwards E, Yearwood C, Sillibourne J, Baralle D, Eccles D: Identification of a de novo BRCA1 mutation in a woman with early onset bilateral breast cancer. Familial cancer. 2009, 8 (4): 479-482. 10.1007\/s10689-009-9270-8.","journal-title":"Familial cancer"},{"key":"868_CR43","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/1471-2350-9-58","volume":"9","author":"TV Hansen","year":"2008","unstructured":"Hansen TV, Bisgaard ML, Jonson L, Albrechtsen A, Filtenborg-Barnkob B, Eiberg H, Ejlertsen B, Nielsen FC: Novel de novo BRCA2 mutation in a patient with a family history of breast cancer. BMC medical genetics. 2008, 9: 58-","journal-title":"BMC medical genetics"}],"container-title":["BMC Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2350-12-134.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2350-12-134\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2350-12-134","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2350-12-134.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T17:03:07Z","timestamp":1630515787000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenet.biomedcentral.com\/articles\/10.1186\/1471-2350-12-134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,11]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["868"],"URL":"https:\/\/doi.org\/10.1186\/1471-2350-12-134","relation":{},"ISSN":["1471-2350"],"issn-type":[{"value":"1471-2350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,11]]},"assertion":[{"value":"14 June 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"134"}}